Intensive Care Unit
Recently Published Documents


TOTAL DOCUMENTS

45106
(FIVE YEARS 22999)

H-INDEX

202
(FIVE YEARS 63)

2021 ◽  
Vol 9 (29) ◽  
pp. 8666-8670
Author(s):  
Ming-Tsung Sun ◽  
I-Cheng Li ◽  
Wei-Shiang Lin ◽  
Gen-Min Lin

2022 ◽  
Vol 12 (1) ◽  
pp. 1-17
Author(s):  
Nagaraj V. Dharwadkar ◽  
Amulya A. Dixit ◽  
Anil K. Kannur ◽  
Mohammad Ali Bandusab Kadampur ◽  
Santosh Joshi

Abstract. The infants admitted in the Neonatal Intensive Care Unit (NICU) always need a Hygienic environment and round the clock observations. Infants or the just born babies always express their physical and emotional needs through cry. Thus, the detection of the reasons behind the infant cry plays a vital role in monitoring the health of the babies in the NICU. In this paper, we have proposed a novel approach for detecting the reasons for Infant's cry. In the proposed approach the cry signal of the infant is captured and from this signal, the unique set of features are extracted using MFCCs, LPCCs, and Pitch. This set of features is used to differentiates the patters signals to recognize the reasons for the cry. The reasons for cry such as hunger, pain, sleep, and discomfort are used to represent different classes. The Neural Network Multilayer classifier is designed to recognize the reasons for the cry using the standard dataset of infant cry. The proposed classifier can achieve accuracy of 93.24% from the combined features of MFCCs, LPCCs and Pitch using


2021 ◽  
Vol 40 (6) ◽  
pp. 321-327
Author(s):  
Sharon C. O'Donoghue ◽  
Meghan Church ◽  
Kristin Russell ◽  
Kelly A. Gamboa ◽  
Jacqueline Hardman ◽  
...  

2021 ◽  
Vol 40 (6) ◽  
pp. 345-354
Author(s):  
Sharon C. O'Donoghue ◽  
Barbara Donovan ◽  
Joanna Anderson ◽  
Jane Foley ◽  
Jean Gillis ◽  
...  

2021 ◽  
pp. 42-51
Author(s):  
A. V. Vlasenko ◽  
A. G. Koryakin ◽  
E. A. Evdokimov ◽  
I. S. Klyuev

The development of medical technologies and the emergence of new methods of respiratory support with extensive capabilities to control positive pressure on the inhale and exhale made it possible to implement non-invasive ventilation. The integration of microprocessors in modern respiratory interfaces, on the one hand, and a deeper understanding of the mechanisms of the pathogenesis of respiratory failure, on the other hand, made it possible to improve and implement various methods of non-invasive respiratory support in everyday clinical practice. The experience gained in recent decades with the use of non-invasive ventilation made it possible to widely use this method of respiratory support in a wide variety of clinical situations. However, the selection of patients for mask ventilation, the choice of method and algorithm for its application, prognosis of effectiveness, prevention of negative effects, as before, remain relevant. This dictates the need to continue studying the clinical efficacy of non-invasive ventilation in patients with respiratory failure of various origins. The review presents the possibilities and limitations of the use of non-invasive respiratory support in patients with respiratory failure in the intensive care unit.


2021 ◽  
Author(s):  
Thu Vo-Pham-Minh ◽  
Van Duong-Thi-Thanh ◽  
Thang Nguyen ◽  
Quyen Phan-Tran-Xuan ◽  
Hoang Phan-Thi ◽  
...  

Author(s):  
Giulia Lorenzoni ◽  
Danila Azzolina ◽  
Aslihan Şentürk Acar ◽  
Luciano Silvestri ◽  
Paola Berchialla ◽  
...  

Abstract Background: The present study aims to explore if a relationship exists between the immediate sharp increase in Intensive Care Unit (ICU) admissions and the mortality rates in Italy. Methods: Official epidemiological data on COVID-19 were employed. The forward lagged (0, 3, 7, 14 days) daily variations in the number of deaths according to the number of days after the outbreak started and the daily increases in ICU admissions were estimated. Results: A direct relationship between the sharp increase of ICU admissions and mortality rates has been shown. Furthermore, the analysis of the forward lagged daily variations in the number of deaths showed that an increase in the daily number of ICU admissions resulted in significantly higher mortality after 3, 7, and 14 days. The most pronounced effect was detected after 7 days, with 250 deaths (95% C.I. 108.1-392.8) for the highest increase in the ICU admissions -from 100 to 200- Conclusions: These results would serve as a warning for the scientific community and the health care decision-makers to prevent a quick and out-of-control saturation of the ICU beds in case of a relapse of the COVID-19 outbreak.


Author(s):  
Victoria Metaxa ◽  
Despina Anagnostou ◽  
Savvas Vlachos ◽  
Nishkantha Arulkumaran ◽  
Sherihane Besemmane ◽  
...  

2021 ◽  
Vol 27 (38) ◽  
pp. 6453-6464
Author(s):  
Ni Shi ◽  
Guo-Dong Sun ◽  
Yuan-Yuan Ji ◽  
Ying Wang ◽  
Yu-Cheng Zhu ◽  
...  

BMJ ◽  
2021 ◽  
pp. n2400
Author(s):  
Michelle Sholzberg ◽  
Grace H Tang ◽  
Hassan Rahhal ◽  
Musaad AlHamzah ◽  
Lisa Baumann Kreuziger ◽  
...  

Abstract Objective To evaluate the effects of therapeutic heparin compared with prophylactic heparin among moderately ill patients with covid-19 admitted to hospital wards. Design Randomised controlled, adaptive, open label clinical trial. Setting 28 hospitals in Brazil, Canada, Ireland, Saudi Arabia, United Arab Emirates, and US. Participants 465 adults admitted to hospital wards with covid-19 and increased D-dimer levels were recruited between 29 May 2020 and 12 April 2021 and were randomly assigned to therapeutic dose heparin (n=228) or prophylactic dose heparin (n=237). Interventions Therapeutic dose or prophylactic dose heparin (low molecular weight or unfractionated heparin), to be continued until hospital discharge, day 28, or death. Main outcome measures The primary outcome was a composite of death, invasive mechanical ventilation, non-invasive mechanical ventilation, or admission to an intensive care unit, assessed up to 28 days. The secondary outcomes included all cause death, the composite of all cause death or any mechanical ventilation, and venous thromboembolism. Safety outcomes included major bleeding. Outcomes were blindly adjudicated. Results The mean age of participants was 60 years; 264 (56.8%) were men and the mean body mass index was 30.3 kg/m 2 . At 28 days, the primary composite outcome had occurred in 37/228 patients (16.2%) assigned to therapeutic heparin and 52/237 (21.9%) assigned to prophylactic heparin (odds ratio 0.69, 95% confidence interval 0.43 to 1.10; P=0.12). Deaths occurred in four patients (1.8%) assigned to therapeutic heparin and 18 patients (7.6%) assigned to prophylactic heparin (0.22, 0.07 to 0.65; P=0.006). The composite of all cause death or any mechanical ventilation occurred in 23 patients (10.1%) assigned to therapeutic heparin and 38 (16.0%) assigned to prophylactic heparin (0.59, 0.34 to 1.02; P=0.06). Venous thromboembolism occurred in two patients (0.9%) assigned to therapeutic heparin and six (2.5%) assigned to prophylactic heparin (0.34, 0.07 to 1.71; P=0.19). Major bleeding occurred in two patients (0.9%) assigned to therapeutic heparin and four (1.7%) assigned to prophylactic heparin (0.52, 0.09 to 2.85; P=0.69). Conclusions In moderately ill patients with covid-19 and increased D-dimer levels admitted to hospital wards, therapeutic heparin was not significantly associated with a reduction in the primary outcome but the odds of death at 28 days was decreased. The risk of major bleeding appeared low in this trial. Trial registration ClinicalTrials.gov NCT04362085 .


Sign in / Sign up

Export Citation Format

Share Document